ClinicalTrials.gov Record History: how to compare changes in a peptide study

01

What the Record History tab can show

A ClinicalTrials.gov study record is not necessarily static. The responsible party posts registration information and later updates status, dates, contacts, protocol fields, and results when applicable. The Record History tab provides a chronology of versions and tools to compare them.

ClinicalTrials.gov's study-record guide says the history can be used to view different versions and compare changes over time. Recent site improvements highlight which modules changed and distinguish changes to outcome measures in the protocol section from changes in the results section. That makes the official history more useful than an undated screenshot or a cached summary.

The history records public database changes, not every internal discussion, draft protocol, regulator interaction, or analysis decision. It is evidence of what the registry displayed on particular dates. Use it as one layer in a larger evidence review.

02

Choose comparison dates that answer a real question

Do not compare only the first and latest versions. Select milestones: the version first posted, the last version before enrollment began, the last version before primary completion, the version before results were submitted or posted, and the version current when a paper was submitted or published if that date can be established.

The purpose is not to hunt for any edit. It is to determine whether the question, outcome, population, and analysis visible before results were known align with what was later reported. An updated contact, recruitment location, or verification date has a different evidentiary meaning from changing a primary outcome after the primary completion date.

Record each version date and the milestone it represents. ClinicalTrials.gov displays submitted and posted dates because quality-control review can separate them. Avoid describing a change as public on the submission date if it was posted later.

• →First submitted and first posted
• →Before enrollment began
• →Before primary completion
• →Before results submission and posting
• →Version contemporaneous with the publication

03

Fields that deserve close comparison

Start with primary and secondary outcome measures: the outcome name, description, time frame, and measurement method. Look for additions, removals, reclassification between primary and secondary, narrower or broader definitions, and changes in when the outcome is measured.

Then compare enrollment type and count, allocation, masking, intervention model, arms, eligibility criteria, age ranges, locations, and study dates. A change from anticipated to actual enrollment after completion is expected; a large enrollment revision should still be understood alongside the participant flow and analysis population.

Review sponsor and collaborator fields, responsible party, study status, why a study stopped, and results modules. For an observational study, focus on the cohort, sampling method, exposure definitions, and outcome timing rather than applying randomized-trial expectations.

04

Updates can be required, routine, or scientifically important

ClinicalTrials.gov instructs responsible parties to update certain status and completion-date fields within specified periods and to make other updates at least annually, with the exact legal requirements depending on the study. Recruitment changes, location closures, corrected dates, and transitions from estimated to actual values can therefore be normal record maintenance.

Protocol amendments can also be legitimate: new safety information, operational feasibility, regulatory feedback, data-quality issues, or scientific learning may justify a change. A registry diff cannot determine motive or whether the amendment was appropriate. Look for the dated protocol amendment, rationale, oversight approval, and whether the analysis accounted for the change.

The most consequential pattern is not merely “something changed” but a material change made after relevant data were available without a transparent explanation, paired with reporting that obscures the original plan. Even then, describe the documented sequence and request clarification rather than alleging misconduct from timing alone.

05

Cross-check the history with results and publications

Open the ClinicalTrials.gov Results tab if results are posted. Compare the participant flow, baseline information, outcome tables, adverse-event information, and analysis population with both the current protocol fields and the earlier versions. Submitted results and posted results are separate statuses, so note which one you are using.

Find the full protocol and statistical analysis plan when available in the registry documents, journal supplement, sponsor site, or regulatory review package. The plan can explain analysis populations, missing-data handling, multiplicity, and amendments that a short registry field cannot.

Finally compare the registry with the paper: trial identifier, enrollment, outcome definitions, time frames, adverse-event reporting, funding, and sponsor role. Search PubMed for corrections, retractions, or expressions of concern. A press release or conference abstract may precede complete results and should not be treated as the final evidence record.

06

A reproducible workflow for peptide-study research

Save the NCT number and current record URL. Export or note the relevant versions, dates, and exact field differences. Use neutral language such as “the primary outcome time frame changed from X in the version posted on date A to Y in the version posted on date B.” That wording is verifiable and avoids guessing why.

Prioritize changes that could alter interpretation: which outcome was primary, who was analyzed, how long participants were followed, and when the change occurred relative to data collection. Minor typographic or contact edits can be recorded but should not crowd out the scientific comparison.

Ask the study sponsor or corresponding author for the amendment and rationale when the public record is unclear. Preserve the response and date. If you publish a summary, link directly to the study and versions, state the limitations of the history, and update your analysis when results, protocols, or corrections appear.

• →NCT number and version dates
• →Exact before-and-after field text
• →Relevant trial milestone
• →Protocol or analysis-plan explanation
• →Results and publication cross-check
• →Uncertainty stated near the conclusion